Teladoc Health Inc [NYSE: TDOC] stock went on a downward path that fall over -4.01% on Monday, amounting to a one-week price increase of more than 8.29%.
Over the last 12 months, TDOC stock dropped by -36.60%. The one-year Teladoc Health Inc stock forecast points to a potential downside of -7.38. The average equity rating for TDOC stock is currently 2.57, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $2.08 billion, with 171.94 million shares outstanding and 168.52 million shares in the current float. Compared to the average trading volume of 5.82M shares, TDOC stock reached a trading volume of 7444641 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Teladoc Health Inc [TDOC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $10.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.57. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Teladoc Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 15, 2024. While these analysts kept the previous recommendation, Jefferies dropped their target price from $8 to $10. The new note on the price target was released on September 17, 2024, representing the official price target for Teladoc Health Inc stock. Previously, the target price had yet another raise to $22, while Cantor Fitzgerald analysts kept a Overweight rating on TDOC stock.
The Average True Range (ATR) for Teladoc Health Inc is set at 0.71, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 0.80. The Price to Book ratio for the last quarter was 1.31, with the Price to Cash per share for the same quarter was set at 6.89. Price to Free Cash Flow for TDOC in the course of the last twelve months was 6.25 with Quick ratio for the last quarter at 1.65.
TDOC Stock Performance Analysis:
Teladoc Health Inc [TDOC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.29. With this latest performance, TDOC shares gained by 27.78% in over the last four-week period, additionally plugging by 3.79% over the last 6 months – not to mention a drop of -36.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 63.83, with the RSI for the last a single of trading hit 64.71, and the three-weeks RSI is set at 62.45 for Teladoc Health Inc [TDOC]. The present Moving Average for the last 50 days of trading for this stock 9.39, while it was recorded at 11.66 for the last single week of trading, and 10.82 for the last 200 days.
Insight into Teladoc Health Inc Fundamentals:
Teladoc Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.65 and a Current Ratio set at 1.69.
TDOC Stock EPS
With the latest financial reports released by the company, Teladoc Health Inc posted -0.14/share EPS, while the average EPS was predicted by analysts to be reported at -0.24/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.09. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TDOC.
Teladoc Health Inc [TDOC] Institutonal Ownership Details
There are presently around $77.24%, or 77.86%% of TDOC stock, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: BLACKROCK INC. with ownership of 21.61 million shares, which is approximately 12.8843%. VANGUARD GROUP INC, holding 17.22 million shares of the stock with an approximate value of $$168.38 million in TDOC stocks shares; and VANGUARD GROUP INC, currently with $$73.17 million in TDOC stock with ownership which is approximately 4.4603%.
